Skip to main content

Research Repository

Advanced Search

CXCR4 and ACKR3 binding agents for imaging applications in cancer

Renard, Isaline

Authors

Isaline Renard



Contributors

Abstract

The chemokine receptors CXCR4 and ACKR3 have been shown to be over-expressed in multiple types of cancer and are usually associated with aggressive phenotypes and poor prognosis. Successfully targeting and imaging the expression levels of these receptors in tumours could allow earlier diagnosis of some cancers, inform treatment selection and lead to better outcome for the patients.
Previously reported AMD3100 conjugates (3 and 4) specific to CXCR4 have been radiolabelled with gallium-68 and evaluated in vivo in tumour-bearing animals. Tumour uptake of the radiotracers was compared to the known CXCR4-specific PET radiotracer, [68Ga]Pentixafor. Blocking with 5 mg/kg of the high affinity Cu2CB-Bicyclam led to a 3- and 6-fold decrease in tumour and liver uptake of [68Ga]Ga4, respectively.
Previous work in the Archibald group has identified a macrocycle derivative (13), that binds to both CXCR4 and ACKR3. Synthesis of 13 has been optimised and semi-preparative HPLC methods were developed for the purification of this compound and its corresponding copper(II) and zinc(II) metal complexes to yield high purity derivatives for the first time to allow biological evaluation. The SAR of these compounds is currently under investigation and preliminary results have already shown affinity below 1 nM for CXCR4 and of ca 100 nM for ACKR3. A synthetic route was developed for a novel compound (14) designed to optimise receptor binding.
As no small molecule or peptide ACKR3-specific PET imaging agent has been reported so far, the possibility of functionalising ACKR3-specific peptides, P20 (23) and FC313 (24), to introduce a chelator amenable to gallium-68 radiolabelling was investigated. The ACKR3 affinity of the several derivatives synthesised was evaluated in vitro with the lead compound showing an IC50 of 1.4 μM.

Citation

Renard, I. (2019). CXCR4 and ACKR3 binding agents for imaging applications in cancer. (Thesis). University of Hull. https://hull-repository.worktribe.com/output/4912463

Thesis Type Thesis
Deposit Date Nov 12, 2024
Publicly Available Date Nov 12, 2024
Keywords Chemistry
Public URL https://hull-repository.worktribe.com/output/4912463
Additional Information Department of Chemistry
University of Hull
Award Date Nov 1, 2019

Files

Thesis (3.6 Mb)
PDF

Copyright Statement
©2019 The author. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder





You might also like



Downloadable Citations